Time short in EU patent debate

The European biotechnology industry is scrambling against a deadline to persuade deadlocked negotiators to scrap a proposed amendment to a European Union biotechnology directive that would make it difficult to patent genes, proteins and other products that have been isolated from the human body.

"The trade associations are working hard, through various routes into Brussels, and through the British government here, to ensure